131 related articles for article (PubMed ID: 16533674)
1. Treatment preference patterns during a videotape decision aid for benign prostatic hyperplasia (BPH).
Wills CE; Holmes-Rovner M; Rovner D; Lillie J; Kelly-Blake K; Bonham V; Williams G
Patient Educ Couns; 2006 Apr; 61(1):16-22. PubMed ID: 16533674
[TBL] [Abstract][Full Text] [Related]
2. Men's theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid.
Holmes-Rovner M; Price C; Rovner DR; Kelly-Blake K; Lillie J; Wills C; Bonham VL
J Gen Intern Med; 2006 Jan; 21(1):56-60. PubMed ID: 16423124
[TBL] [Abstract][Full Text] [Related]
3. Men's interpretations of graphical information in a videotape decision aid.
Pylar J; Wills CE; Lillie J; Rovner DR; Kelly-Blake K; Holmes-Rovner M
Health Expect; 2007 Jun; 10(2):184-93. PubMed ID: 17524011
[TBL] [Abstract][Full Text] [Related]
4. Decision aids for benign prostatic hyperplasia: applicability across race and education.
Rovner DR; Wills CE; Bonham V; Williams G; Lillie J; Kelly-Blake K; Williams MV; Holmes-Rovner M
Med Decis Making; 2004; 24(4):359-66. PubMed ID: 15271274
[TBL] [Abstract][Full Text] [Related]
5. Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid.
Lamers RED; van der Wijden FC; de Angst IB; de Vries M; Cuypers M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Bosch RJLHR; Kil PJM
Urology; 2020 Mar; 137():138-145. PubMed ID: 31899227
[TBL] [Abstract][Full Text] [Related]
6. Enhanced decision-making: the use of a videotape decision-aid for patients with prostate cancer.
Schapira MM; Meade C; Nattinger AB
Patient Educ Couns; 1997 Feb; 30(2):119-27. PubMed ID: 9128614
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia.
van der Wijden FC; de Angst IB; Lamers RED; Cuypers M; de Vries M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Kil PJM
BJU Int; 2019 Jul; 124(1):124-133. PubMed ID: 30589205
[TBL] [Abstract][Full Text] [Related]
8. Does one size fit all? Investigating heterogeneity in men's preferences for benign prostatic hyperplasia treatment using mixed logit analysis.
Eberth B; Watson V; Ryan M; Hughes J; Barnett G
Med Decis Making; 2009; 29(6):707-15. PubMed ID: 19734440
[TBL] [Abstract][Full Text] [Related]
9. Responding to the challenge. A status report on shared decision-making programs.
Kasper JF; Fowler FJ
HMO Pract; 1993 Dec; 7(4):176-81. PubMed ID: 10145929
[TBL] [Abstract][Full Text] [Related]
10. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
[TBL] [Abstract][Full Text] [Related]
11. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia.
Barry MJ; Fowler FJ; Mulley AG; Henderson JV; Wennberg JE
Med Care; 1995 Aug; 33(8):771-82. PubMed ID: 7543639
[TBL] [Abstract][Full Text] [Related]
12. Updated patient information for treatment of benign prostatic hyperplasia: a permanent challenge.
Hartung R
Eur Urol; 1997; 32 Suppl 2():42-4. PubMed ID: 9248813
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
14. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
[TBL] [Abstract][Full Text] [Related]
15. A comparison of web-based versus print-based decision AIDS for prostate cancer screening: participants' evaluation and utilization.
Tomko C; Davis KM; Luta G; Krist AH; Woolf SH; Taylor KL
J Gen Intern Med; 2015 Jan; 30(1):33-42. PubMed ID: 25183475
[TBL] [Abstract][Full Text] [Related]
16. Decision aids for benign prostatic hyperplasia and prostate cancer.
Arterburn D; Wellman R; Westbrook EO; Ross TR; McCulloch D; Handley M; Lowe M; Cable C; Zeliadt SB; Hoffman RM
Am J Manag Care; 2015 Feb; 21(2):e130-40. PubMed ID: 25880488
[TBL] [Abstract][Full Text] [Related]
17. Development of a decision aid for the treatment of benign prostatic hyperplasia: A four stage method using a Delphi consensus study.
Lamers RED; Cuypers M; Garvelink MM; de Vries M; Bosch JLHR; Kil PJM
Patient Educ Couns; 2016 Jul; 99(7):1249-1256. PubMed ID: 26899631
[TBL] [Abstract][Full Text] [Related]
18. Using a trade-off technique to assess patients' treatment preferences for benign prostatic hyperplasia.
Llewellyn-Thomas HA; Williams JI; Levy L; Naylor CD
Med Decis Making; 1996; 16(3):262-82. PubMed ID: 8818125
[TBL] [Abstract][Full Text] [Related]
19. Impact of a shared decision-making program on patients with benign prostatic hyperplasia.
Piercy GB; Deber R; Trachtenberg J; Ramsey EW; Norman RW; Goldenberg SL; Nickel JC; Elhilali M; Perrault JP; Kraetschmer N; Sharpe N
Urology; 1999 May; 53(5):913-20. PubMed ID: 10223483
[TBL] [Abstract][Full Text] [Related]
20. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
McConnell JD; Barry MJ; Bruskewitz RC
Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
